Cytogen Inc - Asset Resilience Ratio

Latest as of December 2025: 32.97%

Cytogen Inc (217330) has an Asset Resilience Ratio of 32.97% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Cytogen Inc's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩20.52 Billion

≈ $13.91 Million USD Cash + Short-term Investments

Total Assets

₩62.24 Billion

≈ $42.18 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Cytogen Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 217330 total asset value.

Liquid Assets Composition Over Time

This chart breaks down Cytogen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Cytogen Inc to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩20.52 Billion	32.97%
Total Liquid Assets	₩20.52 Billion	32.97%

Asset Resilience Insights

Very High Liquidity: Cytogen Inc maintains exceptional liquid asset reserves at 32.97% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Cytogen Inc Industry Peers by Asset Resilience Ratio

Compare Cytogen Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
LONZA GROUP UNSP.ADR 1/10 F:LO3A	Diagnostics & Research	3.04%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	13.42%
Gencurix Inc KQ:229000	Diagnostics & Research	4.01%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Cytogen Inc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Cytogen Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	32.97%	₩20.52 Billion ≈ $13.91 Million	₩62.24 Billion ≈ $42.18 Million	-23.87pp
2024-12-31	56.85%	₩41.20 Billion ≈ $27.92 Million	₩72.48 Billion ≈ $49.12 Million	-16.88pp
2023-12-31	73.72%	₩54.89 Billion ≈ $37.20 Million	₩74.45 Billion ≈ $50.45 Million	+34.66pp
2022-12-31	39.06%	₩16.10 Billion ≈ $10.91 Million	₩41.22 Billion ≈ $27.93 Million	-24.65pp
2021-12-31	63.71%	₩35.38 Billion ≈ $23.97 Million	₩55.53 Billion ≈ $37.63 Million	+7.57pp
2020-12-31	56.14%	₩15.89 Billion ≈ $10.77 Million	₩28.31 Billion ≈ $19.19 Million	-8.89pp
2019-12-31	65.03%	₩12.82 Billion ≈ $8.69 Million	₩19.72 Billion ≈ $13.36 Million	+9.11pp
2018-12-31	55.92%	₩12.72 Billion ≈ $8.62 Million	₩22.75 Billion ≈ $15.42 Million	-23.46pp
2017-12-31	79.38%	₩4.51 Billion ≈ $3.06 Million	₩5.68 Billion ≈ $3.85 Million	+24.16pp
2016-12-31	55.22%	₩2.80 Billion ≈ $1.89 Million	₩5.06 Billion ≈ $3.43 Million	--

pp = percentage points

About Cytogen Inc

KQ:217330 Korea Diagnostics & Research

Market Cap

$48.00 Million

₩70.82 Billion KRW

Market Cap Rank

#22149 Global

#1380 in Korea

Share Price

₩3070.00

Change (1 day)

+0.33%

52-Week Range

₩2320.00 - ₩9420.00

All Time High

₩22599.98